Healthcare Industry News: PHOENIX
News Release - February 21, 2007
Zynex Announces New Chief Financial Officer
LITTLETON, Colo.--(HSMN NewsFeed)--Zynex Medical Holdings, Inc. (OTCBB: ZYNX ) announces today that it has hired Fritz Allison as its new Chief Financial Officer to replace Pete Leveton.Zynex has elected Fritz G. Allison, 47, as Chief Financial Officer of Zynex, effective February 19, 2007. Prior to joining Zynex, Mr. Allison served as a Financial Consultant for MSS Technologies, a PHOENIX-based provider of business application solutions, since 2004. From 2000 until 2004, Mr. Allison held the roles of Vice-President, Controller and Chief Financial Officer of Orange Glo International, Inc., a manufacturer of cleaning products in the consumer package goods industry. Previous positions include Manager of Corporate Accounting for J.D. Edwards & Co, Controller at Powercom-2000 and International Controller for CH2M Hill International.
Fritz Allison holds a B.A. in Business Administration from the University of Southern California and has been a Certified Public Accountant.
Thomas Sandgaard, CEO, comments: "With the replacement and adding Fritz Allison to our team, we believe we are in a strong position to accommodate our current and immediate growth. He has a relevant background from fast-growing and high-tech companies and will be an important cornerstone for managing our growth."
About Zynex Medical Holdings, Inc.
Zynex Medical Holdings, Inc. (founded in 1996) engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove(TM) for stroke and spinal cord injury (SCI) rehabilitation. Zynex's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain.
Safe Harbor Statement
Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, risks and delays associated with product development, risk of market acceptance of products, technology or product obsolescence, competitive risks, reliance on manufacturing partners, dependence on reimbursement from insurance companies, additional capital needs and other risks described in our Form 10-KSB for the year ended December 31, 2005.
Source: Zynex Medical Holdings
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
